Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cyclic-arg-gly-asp-d-phe(n-methyl)val
2. Cyclo(arginyl-glycyl-formylaspartyl-n-methylvalyl)
3. Cyclo(rgdf-n(me)v)
4. Emd 121974
5. Emd121974
1. 188968-51-6
2. Emd 121974
3. Emd-121974
4. 2-[(2s,5r,8s,11s)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic Acid
5. Emd-12192
6. Emd121974
7. Cyclo(l-arginylglycyl-l-alpha-aspartyl-d-phenylalanyl-n-methyl-l-valyl)
8. 4edf46e4gi
9. Chembl429876
10. 2-((2s,5r,8s,11s)-5-benzyl-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic Acid
11. Cyclo(l-arginylglycyl-l-a-aspartyl-d-phenylalanyl-n-methyl-l-valyl)
12. Cilengitide [usan:inn]
13. Unii-4edf46e4gi
14. Cyclo-(arg-gly-asp-dphe-nmeval)
15. Nsc-707544
16. C(rgdfmev)
17. Cyclic-arg-gly-asp-d-phe(n-methyl)val
18. Cilengitide [mi]
19. Cyclo(l-arginylglycyl-l-aspartyl-d-phenylalanyl-n-methyl-l-valyl)
20. Cilengitide [inn]
21. Cilengitide (usan/inn)
22. Cilengitide [usan]
23. Cilengitide [mart.]
24. Cyclo(arginyl-glycyl-formylaspartyl-n-methylvalyl)
25. Schembl34082
26. Cilengitide [who-dd]
27. Gtpl6597
28. Dtxsid9044035
29. Chebi:177833
30. Ex-a1775
31. Zinc3952216
32. Cilengitide Trifluoroacetic Acid Salt
33. Bdbm50235980
34. Nsc774651
35. S6387
36. Akos024257893
37. Cs-1211
38. Cyclo(arg-gly-asp-d-phe-[n-me]val)
39. Db11890
40. Nsc-774651
41. Ncgc00386242-02
42. Ncgc00386242-04
43. Ac-35857
44. As-72195
45. Hy-16141
46. Sw220134-1
47. D03497
48. 968c516
49. A924615
50. Q1091921
51. Cyclo(l-arginylglycyl-l-.alpha.-aspartyl-d-phenylalanyl-n-methyl-l-valyl)
52. [(2s,5r,8s,11s)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13pentaaza-cyclopentadec-2-yl]-acetic Acid
53. 2-[(2s,5r,8s,11s)-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-5-(phenylmethyl)-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic Acid
54. 2-[(2s,5r,8s,11s)-5-benzyl-11-(3-carbamimidamidopropyl)-7-methyl-3,6,9,12,15-pentaoxo-8-(propan-2-yl)-1,4,7,10,13-pentaazacyclopentadecan-2-yl]acetic Acid
| Molecular Weight | 588.7 g/mol |
|---|---|
| Molecular Formula | C27H40N8O7 |
| XLogP3 | -1 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 9 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 238 |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 1020 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of high-grade glioma
ABOUT THIS PAGE
A Cilengitide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cilengitide, including repackagers and relabelers. The FDA regulates Cilengitide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cilengitide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cilengitide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cilengitide supplier is an individual or a company that provides Cilengitide active pharmaceutical ingredient (API) or Cilengitide finished formulations upon request. The Cilengitide suppliers may include Cilengitide API manufacturers, exporters, distributors and traders.
click here to find a list of Cilengitide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cilengitide DMF (Drug Master File) is a document detailing the whole manufacturing process of Cilengitide active pharmaceutical ingredient (API) in detail. Different forms of Cilengitide DMFs exist exist since differing nations have different regulations, such as Cilengitide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cilengitide DMF submitted to regulatory agencies in the US is known as a USDMF. Cilengitide USDMF includes data on Cilengitide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cilengitide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cilengitide suppliers with USDMF on PharmaCompass.
Cilengitide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cilengitide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cilengitide GMP manufacturer or Cilengitide GMP API supplier for your needs.
A Cilengitide CoA (Certificate of Analysis) is a formal document that attests to Cilengitide's compliance with Cilengitide specifications and serves as a tool for batch-level quality control.
Cilengitide CoA mostly includes findings from lab analyses of a specific batch. For each Cilengitide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cilengitide may be tested according to a variety of international standards, such as European Pharmacopoeia (Cilengitide EP), Cilengitide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cilengitide USP).
LOOKING FOR A SUPPLIER?
